PRESS RELEASE published on 05/17/2023 at 17:37, 3 years 5 months ago MLP SE: Invitation to the Annual General Meeting of MLP SE published
PRESS RELEASE published on 05/11/2023 at 07:33, 3 years 5 months ago MLP SE: Q1: MLP remains on course
PRESS RELEASE published on 03/09/2023 at 07:31, 3 years 7 months ago MLP SE: FY 2022: MLP defies difficult environment – 2025 growth course reaffirmed
Published on 10/19/2026 at 23:20, 1 hour 40 minutes ago CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/19/2026 at 22:50, 2 hours 10 minutes ago Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Published on 10/19/2026 at 22:01, 2 hours 59 minutes ago Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing
Published on 10/19/2026 at 22:16, 2 hours 43 minutes ago EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027
Published on 10/19/2026 at 21:22, 3 hours 37 minutes ago EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements
Published on 10/19/2026 at 18:05, 6 hours 54 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 7 hours 15 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:30, 7 hours 30 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 10/19/2026 (French only)
Published on 10/19/2026 at 18:40, 6 hours 19 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:00, 7 hours ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 17:45, 7 hours 15 minutes ago Declaration of transactions on own shares from October 12, 2026 to October 18, 2026
Published on 10/19/2026 at 17:40, 7 hours 20 minutes ago Schneider Electric launches a c. €6.0 billion capital increase, without shareholders’ preferential subscription rights, to partially finance the acquisition of PTC Inc.
